Association with polymorphic marmoset cytochrome P450 2C19 of in vivo hepatic clearances of chirally separated R-omeprazole and S-warfarin using individual marmoset physiologically based pharmacokinetic models. (3rd October 2018)
- Record Type:
- Journal Article
- Title:
- Association with polymorphic marmoset cytochrome P450 2C19 of in vivo hepatic clearances of chirally separated R-omeprazole and S-warfarin using individual marmoset physiologically based pharmacokinetic models. (3rd October 2018)
- Main Title:
- Association with polymorphic marmoset cytochrome P450 2C19 of in vivo hepatic clearances of chirally separated R-omeprazole and S-warfarin using individual marmoset physiologically based pharmacokinetic models
- Authors:
- Kusama, Takashi
Toda, Akiko
Shimizu, Makiko
Uehara, Shotaro
Inoue, Takashi
Uno, Yasuhiro
Utoh, Masahiro
Sasaki, Erika
Yamazaki, Hiroshi - Abstract:
- Abstract: 1. Simulated clearances of R -warfarin and efavirenz were recently reported for individual cynomolgus monkeys genotyped for cytochrome P450 2C19 and 2C9, respectively. To expand and verify this modeling procedure, simulations of R/S -omeprazole and R/S -warfarin clearances after oral administrations in individual marmosets were performed using individual simplified physiologically based pharmacokinetic (PBPK) modeling consisting of gut, liver and central compartments. 2. Pharmacokinetics of R/S -omeprazole were chirally determined using the previously reported plasma microsamples in this study. The areas under the plasma concentration/time curves (AUC) of R -omeprazole and S -warfarin, but not S -omeprazole and R -warfarin, after oral administrations in the P450 2C19 homozygous mutant group were significantly higher than those in the wild-type group. These modeled hepatic intrinsic clearances were also significantly associated with the marmoset P450 2C19 genotypes. Other parameter values, e.g. absorption rate constants or systemic circulation volumes, were not likely determining factors. 3. The reported individual AUC values measured in 4–6 marmosets after oral R -omeprazole and S -warfarin administrations were significantly correlated with the AUC values predicted using the PBPK models after virtual administrations. 4. This study indicates that clearances of R -omeprazole, S -warfarin and related medicines associated with polymorphic P450 2C19 in individualAbstract: 1. Simulated clearances of R -warfarin and efavirenz were recently reported for individual cynomolgus monkeys genotyped for cytochrome P450 2C19 and 2C9, respectively. To expand and verify this modeling procedure, simulations of R/S -omeprazole and R/S -warfarin clearances after oral administrations in individual marmosets were performed using individual simplified physiologically based pharmacokinetic (PBPK) modeling consisting of gut, liver and central compartments. 2. Pharmacokinetics of R/S -omeprazole were chirally determined using the previously reported plasma microsamples in this study. The areas under the plasma concentration/time curves (AUC) of R -omeprazole and S -warfarin, but not S -omeprazole and R -warfarin, after oral administrations in the P450 2C19 homozygous mutant group were significantly higher than those in the wild-type group. These modeled hepatic intrinsic clearances were also significantly associated with the marmoset P450 2C19 genotypes. Other parameter values, e.g. absorption rate constants or systemic circulation volumes, were not likely determining factors. 3. The reported individual AUC values measured in 4–6 marmosets after oral R -omeprazole and S -warfarin administrations were significantly correlated with the AUC values predicted using the PBPK models after virtual administrations. 4. This study indicates that clearances of R -omeprazole, S -warfarin and related medicines associated with polymorphic P450 2C19 in individual marmosets can be simulated using simplified individual PBPK models. … (more)
- Is Part Of:
- Xenobiotica. Volume 48:Number 10(2018:Oct.)
- Journal:
- Xenobiotica
- Issue:
- Volume 48:Number 10(2018:Oct.)
- Issue Display:
- Volume 48, Issue 10 (2018)
- Year:
- 2018
- Volume:
- 48
- Issue:
- 10
- Issue Sort Value:
- 2018-0048-0010-0000
- Page Start:
- 1072
- Page End:
- 1077
- Publication Date:
- 2018-10-03
- Subjects:
- Common marmoset -- CYP2C19 -- microsampling -- polymorphism -- PBPK
Metabolism -- Periodicals
Drugs -- Physiological effect -- Periodicals
Food additives -- Periodicals
Chemicals -- Physiological effect -- Periodicals
Biochemistry -- Periodicals
Pharmaceutical Preparations -- metabolism -- Periodicals
Metabolism -- Periodicals
574.133 - Journal URLs:
- http://informahealthcare.com/journal/xen ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/00498254.2017.1393121 ↗
- Languages:
- English
- ISSNs:
- 0049-8254
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9367.020000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 7013.xml